Advertisement
Screener

GEOVAX LABS, INC. (GOVX) Form D

GEOVAX LABS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2022-06-22: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2022-05-25; Total offering amount $15,000,000.
  • 2022-01-20: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2022-01-19; Total offering amount $10,000,000.
  • 2021-02-25: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2021-02-11; Total offering amount $495,000.
  • 2020-10-08: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2020-09-29; Total offering amount $1,500,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2022-06-22Rule 506(b)Equity; OptionToAcquire2022-05-25$15,000,000$15,000,000$01
2022-01-20Rule 506(b)Equity; OptionToAcquire2022-01-19$10,000,000$10,000,000$01
2021-02-25Rule 506(b)Equity; OptionToAcquire2021-02-11$495,000$495,000$01
2020-10-08Rule 506(b)Equity; OptionToAcquire2020-09-29$1,500,000$1,500,000$08
2020-07-06Rule 506(b)Debt; OptionToAcquire2020-06-26$2,400,000$2,400,000$02
2019-10-31Rule 506(b)Equity; OptionToAcquire2019-07-16$3,256,534$3,256,534$02
2013-12-23Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2013-12-11$1,650,000$1,650,000$03
2012-04-02Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2012-03-21$2,200,000$2,200,000$03
2012-01-13Rule 506Equity; OptionToAcquire2011-12-30$1,500,000$441,210$1,058,79015

Similar stocks

Stock NameCountryMarket CapPE Ratio
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Sunshine Biopharma Inc. (SBFM)$0.003B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
ORAGENICS INC (OGEN)United States$0.002B